Trial · NCT04908475
Participant flow48
How many started, completed or left each group, period by period.
21 to 40 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period B (Week 16 to Week 52) | STARTED | Period B: APR/APR, NR | 78 | |
| Period B (Week 16 to Week 52) | STARTED | Period B: APR/RZB, NR | 83 | |
| Period B (Week 16 to Week 52) | STARTED | Period B: APR/APR, R | 22 | |
| Period B (Week 16 to Week 52) | STARTED | Period B: APR/RZB, R | 20 | |
| Period B (Week 16 to Week 52) | Received ≥ 1 Dose of Study Drug | Period A: APR | 0 | |
| Period B (Week 16 to Week 52) | Received ≥ 1 Dose of Study Drug | Periods A/B: RZB/RZB | 116 | |
| Period B (Week 16 to Week 52) | Received ≥ 1 Dose of Study Drug | Period B: APR/APR, NR | 75 | |
| Period B (Week 16 to Week 52) | Received ≥ 1 Dose of Study Drug | Period B: APR/RZB, NR | 82 | |
| Period B (Week 16 to Week 52) | Received ≥ 1 Dose of Study Drug | Period B: APR/APR, R | 22 | |
| Period B (Week 16 to Week 52) | Received ≥ 1 Dose of Study Drug | Period B: APR/RZB, R | 20 | |
| Period B (Week 16 to Week 52) | Received RZB as Rescue Medication | Period A: APR | 0 | |
| Period B (Week 16 to Week 52) | Received RZB as Rescue Medication | Periods A/B: RZB/RZB | 0 | |
| Period B (Week 16 to Week 52) | Received RZB as Rescue Medication | Period B: APR/APR, NR | 47 | |
| Period B (Week 16 to Week 52) | Received RZB as Rescue Medication | Period B: APR/RZB, NR | 0 | |
| Period B (Week 16 to Week 52) | Received RZB as Rescue Medication | Period B: APR/APR, R | 1 | |
| Period B (Week 16 to Week 52) | Received RZB as Rescue Medication | Period B: APR/RZB, R | 0 | |
| Period B (Week 16 to Week 52) | COMPLETED | Period A: APR | 0 | |
| Period B (Week 16 to Week 52) | COMPLETED | Periods A/B: RZB/RZB | 69 | |
| Period B (Week 16 to Week 52) | COMPLETED | Period B: APR/APR, NR | 42 | |
| Period B (Week 16 to Week 52) | COMPLETED | Period B: APR/RZB, NR | 57 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04908475/flow?page=2